logo
AI Tool to Answer Patient Queries Has Mixed Performance

AI Tool to Answer Patient Queries Has Mixed Performance

Medscape21-05-2025

A novel generative artificial intelligence (genAI) tool for drafting physician responses to patients' online questions showed mixed results, according to a poster presented recently at the Society of General Internal Medicine (SGIM) 2025 Annual Meeting in Hollywood, Florida.
Researchers led by Natalie Lee, MD, MPH, assistant professor of internal medicine at The Ohio State University College of Medicine in Columbus, Ohio, conducted a thematic analysis of 201 genAI responses to real online questions from patients. The AI generator, an Epic draft tool based on GPT-3.5, was trained with four to five rounds of revisions to build the model. The team grouped responses into five categories: Building rapport, gathering information, delivering information accurately and professionally, facilitating next steps and patient decisions, and responding to emotion. Primary care provider reviewers developed a coding system to define strengths and limitations for each domain.
'73% of Drafts Had Limitations'
'We observed both strengths and limitations across all communication domains,' Lee told Medscape Medical News. The data show that 60% of drafts were deemed 'usable,' and 73% had limitations.
In the category of information delivery, for instance, the model performed well in providing accurate information about what to expect with a medical test but gave information about blood donation when the patient's question was about kidney donation. The researchers reported that 65% of AI information delivery responses made incorrect assumptions about clinical context, 36% made incorrect assumptions about workflow, and 24% of the responses were 'simply wrong.'
In responding to emotion, an example limitation was seen when a patient expressed long-standing emotional suffering related to a condition and the reply did not acknowledge patient emotion.
Overall, the researchers wrote, 'While GenAI drafts often contain usable portions, net value added may be limited by inadequacies in more cognitively demanding, critical domains like providing accurate information, asking key questions, and responding to patient emotions. Further optimization is needed to genuinely enhance patient care and provider experience.'
This work provides more data about the usefulness of AI as the need for assistance in fielding patients' questions has intensified with unprecedented volume. 'How do we integrate generative AI technology so that we uphold communication and care quality while also reducing provider burden? It's not clear we have that figured out,' she said.
Framework Adds Novel Assessment
Owais Durrani, DO, an emergency medicine physician with Memorial Hermann Health System in Houston, told Medscape Medical News that the authors' use of a novel framework to assess the quality of medical communications made this study particularly significant.
'Too often, we judge AI tools on surface-level efficiency metrics — how many clicks saved, how many seconds shaved off. But this study looked at deeper clinical domains. The finding that AI performed better in low-risk areas like enabling next steps or basic rapport-building but struggled in areas like delivering accurate information or responding to emotion really highlights where the gaps are. It's a reminder that AI can support the clinical process but shouldn't replace human judgment, especially in patient interactions that require empathy, nuance, or clinical reasoning.'
He said he's open to AI communications, but with caution. 'Many of the drafts are overly verbose, vague, or miss the clinical nuance required to answer a patient's real question,' he said. 'Physicians then have to sift through the noise and rework the content, which in many cases takes as much — or more — time than writing it ourselves. For now, I view AI-generated messages more as a starting point than a solution.'
Lee and Durrani reported having no relevant financial relationships.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Former LeBron James Teammate Tells Wild Club Story About Lakers Star
Former LeBron James Teammate Tells Wild Club Story About Lakers Star

Yahoo

time7 minutes ago

  • Yahoo

Former LeBron James Teammate Tells Wild Club Story About Lakers Star

Former LeBron James Teammate Tells Wild Club Story About Lakers Star originally appeared on Athlon Sports. Los Angeles Lakers star LeBron James takes precise care of his body, which has helped him play 22 seasons in the NBA at an elite level. Advertisement James is 40 years old. He's the oldest active player in the NBA. The average person wouldn't know that by watching him play, as James made the All-NBA Second Team this year and became the oldest player in NBA history to receive an MVP vote, breaking Michael Jordan's 23-year-old record. A four-time MVP, James has played for the Cleveland Cavaliers (twice), Miami Heat and Lakers. He's a four-time champion and a four-time Finals MVP. James is the only player in NBA history to win a Finals MVP Award with three teams. Los Angeles Lakers star LeBron James© Soobum Im-Imagn Images A future Hall of Famer, James won his first two titles with the Heat in 2012 and 2013. Mario Chalmers, who was on those Miami teams, recently told NFL legend Shannon Sharpe that James used to get treatment in the clubs. Advertisement "I tell people this all the time, Bron will really get treatment if he was in the club. Like, he would literally have something on his knees or something on his back inside the club. So it's like why is somebody doing that, like that's a real dedication to just be in the club with treatment." Chalmers said. Sharpe went on asking what were the kind of treatments he is doing in the club. "Not ice bags, it'd be like the stim, like the stim machine that shoot electrolyte or electricity in your knees and stuff like that. He always have something [for] recovery." James has said many times that he takes recovery very seriously. The leading scorer in NBA history has never undergone surgery on his body because of an injury. The small forward is arguably the most durable athlete in NBA history. Advertisement Arguably the greatest player of all time, James has career averages of 27.0 points, 7.5 rebounds, 7.4 assists, 1.5 steals and 0.7 blocks. He's the only player in NBA history to rank top five all-time in points and assists. James, who turns 41 in December, has a player option to return to the Lakers next season worth $52.6 million. The King is widely expected to pick up his option and play his 23rd NBA season. Related: Shai Gilgeous-Alexander Predicted to Repeat Feat Not Seen Since LeBron James This story was originally reported by Athlon Sports on Jun 1, 2025, where it first appeared.

Remission, Attaining CV Risk Targets Drops CVD Risk in Lupus
Remission, Attaining CV Risk Targets Drops CVD Risk in Lupus

Medscape

time38 minutes ago

  • Medscape

Remission, Attaining CV Risk Targets Drops CVD Risk in Lupus

Patients with systemic lupus erythematosus (SLE) had more than double the risk for atherosclerosis progression over 10 years than healthy control individuals, but maintaining cardiovascular risk factor (CVRF) targets and achieving sustained disease remission significantly reduced this risk. METHODOLOGY: Researchers collected carotid ultrasound measurements from 111 patients with SLE and 94 age- and sex-matched controls, including baseline measurements from 2012 to 2013 with follow-up assessments at 3, 7, and 10 years. They tracked carotid plaque progression, CVRF target attainment on the basis of the 2016 European Society of Cardiology Guidelines on cardiovascular disease (CVD) prevention and additional CVD risk modifiers, and incident CVD events over 10 years and looked for predictors of plaque progression. TAKEAWAY: Patients with SLE demonstrated a 2.3-fold higher risk for carotid plaque progression than healthy control individuals (incidence rate ratio [IRR], 2.26; 95% CI, 1.34-3.81; P = .002). = .002). Each CVRF maintained at target during the 10-year follow-up reduced plaque progression risk by 32% (IRR, 0.68; 95% CI, 0.53-0.89; P = .004). = .004). Achievement of definition of remission in SLE for ≥ 75% of follow-up decreased risk for plaque progression by 43% (IRR, 0.57; 95% CI, 0.34-0.95; P = .033). = .033). Persistent triple antiphospholipid antibody positivity increased 10-year risk for incident cardiovascular events in SLE more than sevenfold (hazard ratio, 7.52; P = .014). IN PRACTICE: 'Patients with SLE experience a 2.3-fold higher 10-year atherosclerosis progression risk than [healthy controls], which is significantly mitigated by sustained [cardiovascular risk factor] control and prolonged clinical remission,' the study authors wrote in the abstract. 'Carotid ultrasound may have an additive role in enhancing CVD risk assessment in patients with SLE.' SOURCE: Maria G. Tektonidou, MD, PhD, of the National and Kapodistrian University of Athens, Athens, Greece, presented the study at the 16th International Congress on Systemic Lupus Erythematosus in Toronto. LIMITATIONS: The study sample was relatively small. Carotid ultrasound is dependent on operator skill and experience, which can lead to interobserver and intraobserver variability. DISCLOSURES: Funding information for this research was not provided. Disclosure information for the authors was not available.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store